Can-Fite BioPharma Ltd. (CANF)
1.90
-0.10
(-5.00%)
USD |
NYAM |
Oct 09, 16:00
1.91
+0.01
(+0.53%)
After-Hours: 20:00
Can-Fite BioPharma Market Cap : 4.071M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 4.071M |
| October 08, 2026 | 4.285M |
| October 07, 2026 | 4.499M |
| October 06, 2026 | 4.585M |
| October 05, 2026 | 4.585M |
| October 02, 2026 | 4.675M |
| October 01, 2026 | 4.735M |
| September 30, 2026 | 4.714M |
| September 29, 2026 | 4.671M |
| September 28, 2026 | 4.778M |
| September 25, 2026 | 4.632M |
| September 24, 2026 | 4.649M |
| September 23, 2026 | 4.628M |
| September 22, 2026 | 4.778M |
| September 21, 2026 | 4.756M |
| September 18, 2026 | 4.799M |
| September 17, 2026 | 4.799M |
| September 16, 2026 | 4.799M |
| September 15, 2026 | 4.799M |
| September 14, 2026 | 4.928M |
| September 11, 2026 | 4.992M |
| September 10, 2026 | 4.628M |
| September 09, 2026 | 4.692M |
| September 08, 2026 | 4.906M |
| September 04, 2026 | 4.778M |
| Date | Value |
|---|---|
| September 03, 2026 | 5.035M |
| September 02, 2026 | 3.093M |
| September 01, 2026 | 4.312M |
| August 31, 2026 | 4.167M |
| August 28, 2026 | 4.456M |
| August 27, 2026 | 4.416M |
| August 26, 2026 | 4.351M |
| August 25, 2026 | 4.351M |
| August 24, 2026 | 4.390M |
| August 21, 2026 | 4.364M |
| August 20, 2026 | 4.390M |
| August 19, 2026 | 4.560M |
| August 18, 2026 | 4.521M |
| August 17, 2026 | 4.692M |
| August 14, 2026 | 4.456M |
| August 13, 2026 | 4.456M |
| August 12, 2026 | 4.508M |
| August 11, 2026 | 4.338M |
| August 10, 2026 | 4.207M |
| August 07, 2026 | 4.508M |
| August 06, 2026 | 4.665M |
| August 05, 2026 | 4.194M |
| August 04, 2026 | 4.180M |
| August 03, 2026 | 4.154M |
| July 31, 2026 | 4.128M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLineRx Ltd. | 9.680M |
| XTL Biopharmaceuticals Ltd. | 4.684M |
| Kamada Ltd. | 466.17M |
| Eocene Ltd. | 3.545M |
| Revium Recovery, Inc. | 86.84M |
Market Cap Related Metrics
| PS Ratio | 7.379 |
| Price to Book Value | 1.380 |
| Price | 1.90 |
| Earnings Yield | -331.5% |